Staff Profile

My research addresses clinical and policy issues relevant to the earlier diagnosis of cancer. I chaired the CRUK-funded CanTest Collaborative (www.CanTest.org) and am the clinical lead for the National Cancer Diagnosis Audit. I collaborate with Public Health England and colleagues at UCL on research that utilises the NCDA dataset.

• Articles

  • Cranfield BM, Koo MM, Abel GA, Swann R, McPhail S, Rubin GP, Lyratzopoulos G. Primary care blood tests before cancer diagnosis: National Cancer Diagnosis Audit data. British Journal of General Practice 2023, 73(727), e95-e103.
  • Ghimire B, Landy R, Maroni R, Smith SG, Debiram-Beecham I, Sasieni PD, Fitzgerald RC, Rubin G, Walter FM, Waller J, Attwood S, Parmar M, Delaney B, de Caestecker J, Atkin W, Hackshaw A, van Heyningen C, Underwood T, Stella A, Saxby C, Lorincz A, Turnbull N, Doorbar J, Mannion-Krase G, Kaimi I, Kasanicki M, Kelleher S, Stockley L, Assari T, Kadyan S, Hollamby V, Edwards K, MacDonald H, Shaw V, Leishman H, Roper H, McCloskey K, Jung H, Phillips A, Masjak-Newman G, Fell K, Collins H, Zolle O, McGlone P, Crabb T, Merrin L, Cross M, Jones A, Simpson T, Murray E, Perugia A, Thompson M, Dumbleton J, Morar M, Frowd N, Hardcastle A, Carmichael D, Maxton F, Farnworth F, Baddeley E, Offman J. Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial. BMC Gastroenterology 2023, 23(1), 7.
  • Dobson C, Deane J, Macdonald S, Murchie P, Ellwood C, Angell L, Rubin G. Barriers to Early Presentation amongst Rural Residents Experiencing Symptoms of Colorectal Cancer: A Qualitative Interview Study. Cancers 2023, 15(1), 274.
  • Dobson C, Brown S, Russell A, Rubin G. Risk and the importance of absent symptoms in constructions of the ‘cancer candidate’. Health, Risk and Society 2022, 24(5-6), 225-240.
  • Stevenson DJ, Avery AJ, Coupland C, Hobbs FDR, Kendrick D, Moore MV, Morris C, Rubin GP, Smith MD, Hawkey CJ, Dumbleton JS. Recruitment to a large scale randomised controlled clinical trial in primary care: the Helicobacter Eradication Aspirin Trial (HEAT). Trials 2022, 23(1), 140.
  • Maroni R, Barnes J, Offman J, Scheibl F, Smith SG, Debiram-Beecham I, Waller J, Sasieni P, Fitzgerald RC, Rubin G, Walter FM. Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial. BMJ Open 2022, 12(4), e054258.
  • Koo MM, Swann R, McPhail S, Abel GA, Renzi C, Rubin GP, Lyratzopoulos G. Morbidity and measures of the diagnostic process in primary care for patients subsequently diagnosed with cancer. Family Practice 2022, 39(4), 623-632.
  • Hawkey C, Avery A, Coupland CAC, Crooks C, Dumbleton J, Hobbs FDR, Kendrick D, Moore M, Morris C, Rubin G, Smith M, Stevenson D, Mant DC, Ford AC, Macdonald TM, Bradburn M, Klauza CA, Shone A, Logan RF, Deeks JJ, McColl KEL, Goddard AF, Stevens R, Sami S, Haughney J, Cupples ME, Morar M, O'Brien W. Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial. The Lancet 2022, 400(10363), 1597-1606.
  • Rubin G, Walter FM, Emery J, Hamilton W, Hoare Z, Howse J, Nixon C, Srivastava T, Thomas C, Ukoumunne OC, Usher-Smith JA, Whyte S, Neal RD. Electronic clinical decision support tool for assessing stomach symptoms in primary care (ECASS): A feasibility study. BMJ Open 2021, 11(3), e041795.
  • Koo MM, Unger-Saldana K, Mwaka AD, Corbex M, Ginsburg O, Walter FM, Calanzani N, Moodley J, Rubin GP, Lyratzopoulos G. Conceptual framework to guide early diagnos programs for symptomatic cancer as part of global cancer control. Journal of Global Oncology 2021, 7, 35-45.
  • Koo MM, Swann R, McPhail S, Abel GA, Renzi C, Rubin GP, Lyratzopoulos G. The prevalence of chronic conditions in patients diagnosed with one of 29 common and rarer cancers: A cross-sectional study using primary care data. Cancer Epidemiology 2020, 69, 101845.
  • Dobson C, Rubin G, Murchie P, Macdonald S, Sharp L. Reconceptualising rural cancer inequalities: Time for a new research agenda. International Journal of Environmental Research and Public Health 2020, 17(4), 1455.
  • Koo MM, Swann R, McPhail S, Abel GA, Elliss-Brookes L, Rubin GP, Lyratzopoulos G. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study. The Lancet Oncology 2020, 21(1), 73-79.
  • Humphrys E, Walter FM, Rubin G, Emery JD, Johnson M, Richards A, Fitzgerald RC, Viswanath YKS, Burt J. Patient symptom experience prior to a diagnosis of oesophageal or gastric cancer: a multi-methods study. BJGP Open 2020, 4(1).
  • Chapman D, Poirier V, Vulkan D, Fitzgerald K, Rubin G, Hamilton W, Duffy SW. First results from five multi-disciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer. British Journal of Cancer 2020, 123, 722-729.
  • Fitzgerald RC, Di Pietro M, O'Donovan M, Maroni R, Muldrew B, Debiram-Beecham I, Gehrung M, Offman J, Tripathi M, Smith SG, Aigret B, Walter FM, Rubin G, Sasieni P. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. The Lancet 2020, 396(10247), 333-344.
  • Pearson C, Poirier V, Fitzgerald K, Rubin G, Hamilton W. Cross-sectional study using primary care and cancer registration data to investigate patients with cancer presenting with non-specific symptoms. BMJ Open 2020, 10, e033008.
  • Helsper CW, Campbell C, Emery J, Neal RD, Li L, Rubin G, vanWeert H, Vedsted P, Walter FM, Weller D, Nekhlyudov L. Cancer has not gone away: a primary care perspective to support a balanced approach to timely cancer diagnosis during COVID-19. European Journal of Cancer Care 2020, 29(5), e13290.
  • Humphrys E, Burt J, Rubin G, Emery JD. The influence of health literacy on the timely diagnosis of symptomatic cancer: a systematic review. European Journal of Cancer Care 2019, 28(1), e12920.
  • Swann R, Lyratzopoulos G, Rubin G, Pickworth E, McPhail S. The frequency, nature and impact of GP-assessed avoidable delays in a population-based cohort of cancer patients. Cancer Epidemiology 2019, 64, 101617.
  • Koo MM, Rubin G, McPhail S, Lyratzopoulos G. Incidentally diagnosed cancer and common preceding clinical scenarios: a cross-sectional descriptive analysis of english audit data. BMJ Open 2019, 9, e028362.
  • Walter FM, Thompson MJ, Wellwood I, Abel GA, Hamilton W, Johnson M, Lyratzopoulos G, Messenger MP, Neal RD, Rubin G, Singh H, Spencer A, Sutton S, Vedsted P, Emery JD. Evaluating diagnostic strategies for early detection of cancer: the CanTest framework. BMC Cancer 2019, 19, 58.
  • Renzi C, Kaushal A, Emery J, Hamilton W, Neal RD, Rachet B, Rubin G, Singh H, Walter FM, de Wit N, Lyratzopoulos G. Comorbid chronic diseases and cancer diagnosis: disease specific effects and underlying mechanisms. Nature Reviews Clinical Oncology 2019, 16, 746-761.
  • Mendonca S, Abel GA, Gildea C, McPhail S, Peake MD, Rubin G, Singh H, Hamilton W, Walter FM, Roland MO, Lyratzopoulos G. Associations between general practice characteristics with use of urgent referrals for suspected cancer and endoscopies: a cross-sectional ecological study. Family Practice 2019, 36(5), 573-580.
  • Dobson C, Russell A, Brown S, Rubin G. The role of social context in symptom appraisal and help‐seeking among people with lung or colorectal symptoms: A qualitative interview study. European Journal of Cancer Care 2018, 27(2), e12815.
  • Koo MM, von Wagner C, Abel GA, McPhail S, Hamilton W, Rubin GP, Lyratzopoulos G. The nature and frequency of abdominal symptoms in cancer patients and their associations with time to help-seeking: evidence from a national audit of cancer diagnosis. Journal of Public Health 2018, 40(3), e388-e395.
  • Coxon D, Campbell C, Walter FM, Scott SE, Neal RD, Vedsted P, Emery P, Rubin G, Hamilton W, Weller D. The Aarhus statement on cancer diagnostic research: turning recommendations into new survey instruments. BMC Health Services Research 2018, 18, 677.
  • Rubin G, Walter FM, Emery J, de Wit N. Reimagining the diagnostic pathway for gastrointestinal cancer. Nature Reviews Gastroenterology and Hepatology 2018, 15, 181-188.
  • Swann R, McPhail S, Witt J, Shand B, Abel GA, Hiom S, Rashbass J, Lyratzopoulos G, Rubin G. Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit. British Journal of General Practice 2018, 68, e63-e72.
  • Stanciu MA, Law R-J, Nafees S, Hendry M, Yeo ST, Hiscock J, Lewis R, Edwards RT, Williams NH, Brain K, Brocklehurst P, Carson-Stevens A, Dolwani S, Emery J, Hamilton W, Hoare Z, Lyratzopoulos G, Rubin G, Smits S, Vedsted P, Walter F, Wilkinson C, Neal RD, Williams L, Surgey A, Rose J, Goulden N, on behalf of The WICKED Team. Development of an intervention to expedite cancer diagnosis through primary care: A protocol. BJGP Open 2018, 2(3), bjgpopen18X101595.
  • Offman J, Muldrew B, O'Donovan M, Debiram-Beecham I, Pesola F, Kaimi I, Smith SG, Wilson A, Khan Z, Lao-Sirieix P, Aigret B, Walter FM, Rubin G, Morris S, Jackson C, Sasieni P, Fitzgerald RC, on behalf of the BEST3 Trial Team. Barrett's oESophagus trial 3 (BEST3): Study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux. BMC Cancer 2018, 18, 784.
  • Lyratzopoulos G, Mendonca S, Gildea C, McPhail S, Peake MD, Rubin G, Singh H, Hamilton W, Walter FM, Roland M, Abel GA. Associations between diagnostic activity and measures of patient experience in primary care. British Journal of General Practice 2018, 68, e9-e17.
  • Mills K, Birt L, Emery JD, Hall N, Banks J, Johnson M, Lancaster J, Hamilton W, Rubin GP, Walter FM. Understanding symptom appraisal and help-seeking in people with symptoms suggestive of pancreatic cancer: A qualitative study. BMJ Open 2017, 7(9), e015682.
  • Koo MM, von Wagner C, Abel GA, McPhail S, Rubin GP, Lyratzopoulos G. Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis. Cancer Epidemiology 2017, 48, 140-146.
  • Banks J, Wye L, Hall N, Rooney J, Walter FM, Hamilton W, Gjini A, Rubin G. The researchers' role in knowledge translation: a realist evaluation of the development and implementation of diagnostic pathways for cancer in two United Kingdom localities. Health Research Policy and Systems 2017, 15, 103.
  • Tørring ML, Murchie P, Hamilton W, Vedsted P, Esteva M, Lautrup M, Rubin G. Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries. British Journal of Cancer 2017, 117, 888-897.
  • Stapley SA, Rubin GP, Alsina D, Shephard EA, Rutter MD, Hamilton WT. Clinical features of bowel disease in patients aged <50 years in primary care: A large case-control study. British Journal of General Practice 2017, 67(658), e336-e344.
  • Walter FM, Emery JD, Mendonca S, Hall N, Morris HC, Mills K, Dobson C, Bankhead C, Johnson M, Abel GA, Rutter MD, Hamilton W, Rubin GP. Symptoms and patient factors associated with longer time to diagnosis for colorectal cancer: Results from a prospective cohort study. British Journal of Cancer 2016, 115(5), 533-541.
  • Walter FM, Mills K, Mendonca SC, Abel GA, Basu B, Carroll N, Ballard S, Lancaster J, Hamilton W, Rubin GP, Emery JD. Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study. The Lancet Gastroenterology and Hepatology 2016, 1(4), 298-306.
  • Forrest LF, Sowden S, Rubin G, White M, Adams J. Socio-economic inequalities in stage at diagnosis, and in time intervals on the lung cancer pathway from first symptom to treatment: systematic review and meta-analysis. Thorax 2016, 72(5), 430-436.
  • Hughes DL, Neal RD, Lyratzopoulos G, Rubin G. Profiling for primary-care presentation, investigation and referral for liver cancers: Evidence from a national audit. European Journal of Gastroenterology and Hepatology 2016, 28(4), 428-432.
  • Nicholson B, Mant D, Shinkins B, Rose P, Neal R, Hart N, Hamilton W, Rubin G. International variation in adherence to referral guidelines for suspected cancer: A secondary analysis of survey data. British Journal of General Practice 2016, 66(643), e106-e113.
  • Moore HJ, Nixon C, Tariq A, Emery J, Hamilton W, Hoare Z, Kershenbaum A, Neal RD, Ukoumunne OC, Usher-Smith J, Walter FM, Whyte S, Rubin G. Evaluating a computer aid for assessing stomach symptoms (ECASS): Study protocol for a randomised controlled trial. Trials 2016, 17, 184.
  • Hall N, Birt L, Rees CJ, Walter FM, Elliot S, Ritchie M, Weller D, Rubin G. Concerns, perceived need and competing priorities: a qualitative exploration of decision-making and non-participation in a population-based flexible sigmoidoscopy screening programme to prevent colorectal cancer. BMJ Open 2016, 6(11), e012304.
  • Moller H, Gildea C, Meechan D, Rubin G, Round T, Vedsted P. Use of the English urgent referral pathway for suspected cancer and mortality in patients with cancer: cohort study. BMJ 2015, 351, h5102.
  • Forrest LF, Adams J, Rubin G, White M. The role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: population-based, data-linkage study. Thorax 2015, 70(2), 138-145.
  • Mitchell ED, Rubin G, Merriman L, Macleod U. The role of primary care in cancer diagnosis via emergency presentation: qualitative synthesis of significant event reports. British Journal of Cancer 2015, 112, S50-S56.
  • Lyratzopoulos G, Saunders CL, Abel GA, McPhail S, Neal RD, Wardles J, Rubin GP. The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers. British Journal of Cancer 2015, 112, S35-S40.
  • Dumbleton JS, Avery AJ, Coupland C, Hobbs FDR, Kendrick D, Moore MV, Morris C, Rubin GP, Smith MD, Stevenson DJ, Hawkey CJ. The Helicobacter Eradication Aspirin Trial (HEAT): A Large Simple Randomised Controlled Trial Using Novel Methodology in Primary Care. EBioMedicine 2015, 2(9), 1200-1204.
  • Walter FM, Rubin G, Bankhead C, Morris HC, Hall N, Mills K, Dobson C, Rintoul RC, Hamilton W, Emery J. Symptoms and other factors associated with time to diagnosis and stage of lung cancer: a prospective cohort study. British Journal of Cancer 2015, 112, S6-S13.
  • Hall N, Birt L, Banks J, Emery J, Mills K, Johnson M, Rubin GP, Hamilton W, Walter FM. Symptom appraisal and healthcare-seeking for symptoms suggestive of colorectal cancer: a qualitative study. BMJ Open 2015, 5(10), e008448.
  • Close H, Mason JM, Wilson DW, Hungin APS, Jones R, Rubin G. Risk of ischaemic heart disease in patients with inflammatory bowel disease: Cohort study using the general practice research database. PLoS ONE 2015, 10(10), e0139745.
  • Bevan R, Rubin G, Sofianopoulou E, Patnick J, Rees CJ. Implementing a national flexible sigmoidoscopy screening program: results of the English early pilot. Endoscopy 2015, 47(3), 225-231.
  • Rubin GP, Saunders CL, Abel GA, Mcphail S, Lyratzopoulos G, Neal RD. Impact of investigations in general practice on timeliness of referral for patients subsequently diagnosed with cancer: Analysis of national primary care audit data. British Journal of Cancer 2015, 112(4), 676-687.
  • Hamilton W, Stapley S, Campbell C, Lyratzopoulos G, Rubin G, Neal RD. For which cancers might patients benefit most from expedited symptomatic diagnosis? Construction of a ranking order by a modified Delphi technique. BMC Cancer 2015, 15(1), 820.
  • Green T, Martins T, Hamilton W, Rubin G, Elliott K, Macleod U. Exploring GPs' experiences of using diagnostic tools for cancer: a qualitative study in primary care. Family Practice 2015, 32(1), 101-105.
  • Rose PW, Rubin G, Perera-Salazar R, Almberg SS, Barisic A, Dawes M, Grunfeld E, Hart N, Neal RD, Pirotta M, Sisler J, Konrad G, Toftegaard BS, Thulesius H, Vedsted P, Young J, Hamilton W. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey. BMJ Open 2015, 5(5), e007212.
  • Hall NJ, Rubin GP, Dobson C, Weller D, Wardle J, Ritchie M, Rees CJ. Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer. Health Expectations 2015, 18(5), 1645-1657.
  • Rubin G, Gildea C, Shelton J, Ablett-Spence I. Assessing the impact of an English national initiative for early cancer diagnosis in primary care. British Journal of Cancer 2015, 112, S57-S64.
  • Din NU, Ukoumunne OC, Rubin G, Hamilton W, Carter B, Stapley S, Neal RD. Age and gender variations in cancer diagnostic intervals in 15 cancers: Analysis of data from the UK clinical practice research datalink. PLoS ONE 2015, 10(5), e0127717.
  • Keeble S, Abel GA, Saunders CL, McPhail S, Walter FM, Neal RD, Rubin GP, Lyratzopoulos G. Variation in promptness of presentation among 10,297 patients subsequently diagnosed with one of 18 cancers: Evidence from a National Audit of Cancer Diagnosis in Primary Care. International Journal of Cancer 2014, 135(5), 1220-1228.
  • Forrest LF, White M, Rubin G, Adams J. The role of patient, tumour and system factors in socioeconomic inequalities in lung cancer treatment: population-based study. British Journal of Cancer 2014, 111(3), 608-618.
  • Forrest LF, Sowden S, Rubin G, White M, Adams J. Socio-economic inequalities in patient, primary care, referral, diagnostic, and treatment intervals on the lung cancer care pathway: protocol for a systematic review and meta-analysis. Systematic Reviews 2014, 3(30), 1-5.
  • Lyratzopoulos G, Wardle J, Rubin G. Rethinking diagnostic delay in cancer: how difficult is the diagnosis?. BMJ 2014, 349, g7400.
  • Dobson CM, Russell AJ, Rubin GP. Patient delay in cancer diagnosis: what do we really mean and can we be more specific?. BMC Health Services Research 2014, 14, 1-6.
  • Bevan R, Lee TJW, Nickerson C, Rubin G, Rees CJ. Non-neoplastic findings at colonoscopy after positive faecal occult blood testing: Data from the English Bowel Cancer Screening Programme. Journal of Medical Screening 2014, 21(2), 89-94.
  • Brown S, Castelli M, Hunter DJ, Erskine J, Vedsted P, Foot C, Rubin G. How might healthcare systems influence speed of cancer diagnosis: A narrative review. Social Science and Medicine 2014, 116, 56-63.
  • Forrest LF, Adams J, White M, Rubin G. Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: population-based, data-linkage study. British Journal of Cancer 2014, 1843-1851.
  • Rose PW, Hamilton W, Aldersey K, Barisic A, Dawes M, Foot C, Grunfeld E, Hart N, Neal RD, Pirotta M, Sisler J, Thulesius H, Vedsted P, Young J, Rubin G. Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions. BMC Family Practice 2014, 15, 1-8.
  • Neal RD, Din NU, Hamilton W, GBRoumunne OC, Carter B, Stapley S, Rubin G. Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database. British Journal of Cancer 2014, 110(3), 584-592.
  • Dobson C, Rubin G. Aestheticising Cancer. British Journal of General Practice 2014, 64(625), 415.
  • Henderson E, Rubin G. A model of roles and responsibilities in oral health promotion based on perspectives of a community-based initiative for pre-school children in the UK. British Dental Journal 2014, 216(5), 1-6.
  • Forrest L, Adams J, Wareham H, Rubin G, White M. Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLoS Medicine 2013, 10(2), e1001376.
  • Hall NJ, Rubin GP, Charnock A. Intentional and inadvertent non-adherence in adult coeliac disease. A cross-sectional survey. Appetite 2013, 68, 56-62.

• Note

  • Rubin G, Walter F, Emery J, Neal R, Hamilton W, Wardle J. Research into practice: prompt diagnosis of cancer in primary care. British Journal of General Practice 2014, 64(625), 428-430.

• Reviews

  • Koo MM, Hamilton W, Walter FM, Rubin GP, Lyratzopoulos G. Symptom Signatures and Diagnostic Timeliness in Cancer Patients: A Review of Current Evidence. Neoplasia 2018, 20(2), 165-174.
  • Hamilton W, Walter FM, Rubin G, Neal RD. Improving early diagnosis of symptomatic cancer. Nature Reviews Clinical Oncology 2016, 13(12), 740-749.
  • Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, Fahey T, Grassi L, Grunfeld E, Gupta S, Hamilton W, Hiom S, Hunter D, Lyratzopoulos G, Macleod U, Mason R, Mitchell G, Neal RD, Peake M, Roland M, Seifert B, Sisler J, Sussman J, Taplin S, Vedsted P, Voruganti T, Walter F, Wardle J, Watson E, Weller D, Wender R, Whelan J, Whitlock J, Wilkinson C, de Wit N, Zimmermann C. The expanding role of primary care in cancer control. The Lancet Oncology 2015, 16(12), 1231-1272.
  • Henderson EJ, Ells LJ, Rubin GP, Hunter DJ. Systematic review of the use of data from national childhood obesity surveillance programmes in primary care: A conceptual synthesis. Obesity Reviews 2015, 16(11), 962-971.
  • Brown S, Bevan R, Rubin G, Nixon C, Dunn S, Panter S, Rees CJ. Patient-derived measures of GI endoscopy: A meta-narrative review of the literature. Gastrointestinal Endoscopy 2015, 81(5), 1130-1140.e9.
  • Hungin APS, Becher A, Cayley B, Heidelbaugh JJ, Muris JWM, Rubin G, Seifert B, Russell A, De Wit NJ. Irritable bowel syndrome: An integrated explanatory model for clinical practice. Neurogastroenterology and Motility 2015, 27(6), 750-763.
  • Hungin APS, Molloy-Bland M, Claes R, Heidelbaugh J, Cayley WE, Muris J, Seifert B, Rubin G, De Wit N. Systematic review: The perceptions, diagnosis and management of irritable bowel syndrome in primary care - A Rome Foundation Working Team Report. Alimentary Pharmacology and Therapeutics 2014, 40(10), 1133-1145.
  • Hall NJ, Rubin G, Charnock A. Systematic review: Adherence to a gluten-free diet in adult patients with coeliac disease. Alimentary Pharmacology and Therapeutics 2009, 30(4), 315-330.